Dermata Average Assets vs Tangible Asset Value Analysis

DRMA Stock  USD 0.39  0.01  2.50%   
Trend analysis of Dermata Therapeutics balance sheet accounts such as Total Current Liabilities of 1.5 M or Total Stockholder Equity of 6.7 M provides information on Dermata Therapeutics' total assets, liabilities, and equity, which is the actual value of Dermata Therapeutics to its prevalent stockholders. By breaking down trends over time using Dermata Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dermata Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
For information on how to trade Dermata Stock refer to our How to Trade Dermata Stock guide.

About Dermata Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Dermata Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Dermata Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Dermata Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Dermata currently owns. An asset can also be divided into two categories, current and non-current.

Dermata Therapeutics Balance Sheet Chart

Dermata Therapeutics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Dermata Therapeutics uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, Dermata Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 7.3 M, whereas Total Assets are forecasted to decline to about 6.4 M.

Total Assets

Total assets refers to the total amount of Dermata Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Dermata Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Dermata Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Dermata Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from Dermata Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dermata Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dermata Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
For information on how to trade Dermata Stock refer to our How to Trade Dermata Stock guide.The current year's Selling General Administrative is expected to grow to about 4.2 B. The current year's Issuance Of Capital Stock is expected to grow to about 6.9 M
 2021 2022 2023 2024 (projected)
Interest Expense45.6K63.6K57.2K111.4K
Depreciation And Amortization14.1K9.7K11.1K7.0K

Dermata Therapeutics fundamental ratios Correlations

0.73-0.47-0.440.950.95-0.41-0.98-0.740.471.00.71-0.411.00.420.470.960.87-0.741.00.730.721.00.990.72-0.93
0.73-0.50.140.780.78-0.39-0.64-0.770.490.720.38-0.390.720.480.490.810.87-0.280.760.951.00.730.641.0-0.82
-0.47-0.50.13-0.63-0.630.930.540.85-1.0-0.470.110.93-0.47-0.99-1.0-0.45-0.70.35-0.45-0.63-0.48-0.47-0.43-0.480.65
-0.440.140.13-0.44-0.440.140.570.28-0.14-0.45-0.120.14-0.45-0.15-0.13-0.41-0.320.91-0.410.10.15-0.44-0.580.150.39
0.950.78-0.63-0.441.0-0.59-0.96-0.90.630.950.49-0.590.950.610.630.970.95-0.770.960.840.780.950.930.78-1.0
0.950.78-0.63-0.441.0-0.6-0.96-0.90.630.950.48-0.60.950.610.630.970.95-0.770.960.840.780.950.930.78-1.0
-0.41-0.390.930.14-0.59-0.60.50.82-0.95-0.410.11.0-0.41-0.95-0.95-0.41-0.590.33-0.4-0.6-0.37-0.41-0.36-0.370.61
-0.98-0.640.540.57-0.96-0.960.50.77-0.54-0.98-0.630.5-0.98-0.5-0.54-0.94-0.860.82-0.97-0.68-0.63-0.98-0.99-0.630.93
-0.74-0.770.850.28-0.9-0.90.820.77-0.86-0.73-0.110.82-0.73-0.86-0.86-0.81-0.930.61-0.75-0.87-0.76-0.74-0.7-0.760.92
0.470.49-1.0-0.140.630.63-0.95-0.54-0.860.47-0.11-0.950.471.01.00.450.69-0.350.450.640.470.470.420.47-0.65
1.00.72-0.47-0.450.950.95-0.41-0.98-0.730.470.71-0.411.00.420.470.960.86-0.741.00.720.711.00.990.71-0.92
0.710.380.11-0.120.490.480.1-0.63-0.11-0.110.710.10.71-0.19-0.110.590.31-0.280.710.330.380.710.680.38-0.44
-0.41-0.390.930.14-0.59-0.61.00.50.82-0.95-0.410.1-0.41-0.95-0.95-0.41-0.590.33-0.4-0.6-0.37-0.41-0.36-0.370.61
1.00.72-0.47-0.450.950.95-0.41-0.98-0.730.471.00.71-0.410.420.470.960.86-0.741.00.720.711.00.990.71-0.92
0.420.48-0.99-0.150.610.61-0.95-0.5-0.861.00.42-0.19-0.950.421.00.430.69-0.350.410.620.460.420.380.46-0.64
0.470.49-1.0-0.130.630.63-0.95-0.54-0.861.00.47-0.11-0.950.471.00.450.69-0.350.450.640.470.470.420.47-0.65
0.960.81-0.45-0.410.970.97-0.41-0.94-0.810.450.960.59-0.410.960.430.450.92-0.750.970.820.810.960.950.81-0.97
0.870.87-0.7-0.320.950.95-0.59-0.86-0.930.690.860.31-0.590.860.690.690.92-0.670.870.880.860.870.840.86-0.97
-0.74-0.280.350.91-0.77-0.770.330.820.61-0.35-0.74-0.280.33-0.74-0.35-0.35-0.75-0.67-0.72-0.32-0.28-0.74-0.83-0.280.74
1.00.76-0.45-0.410.960.96-0.4-0.97-0.750.451.00.71-0.41.00.410.450.970.87-0.720.760.761.00.980.76-0.94
0.730.95-0.630.10.840.84-0.6-0.68-0.870.640.720.33-0.60.720.620.640.820.88-0.320.760.950.730.640.95-0.87
0.721.0-0.480.150.780.78-0.37-0.63-0.760.470.710.38-0.370.710.460.470.810.86-0.280.760.950.720.631.0-0.81
1.00.73-0.47-0.440.950.95-0.41-0.98-0.740.471.00.71-0.411.00.420.470.960.87-0.741.00.730.720.990.72-0.93
0.990.64-0.43-0.580.930.93-0.36-0.99-0.70.420.990.68-0.360.990.380.420.950.84-0.830.980.640.630.990.63-0.9
0.721.0-0.480.150.780.78-0.37-0.63-0.760.470.710.38-0.370.710.460.470.810.86-0.280.760.951.00.720.63-0.81
-0.93-0.820.650.39-1.0-1.00.610.930.92-0.65-0.92-0.440.61-0.92-0.64-0.65-0.97-0.970.74-0.94-0.87-0.81-0.93-0.9-0.81
Click cells to compare fundamentals

Dermata Therapeutics Account Relationship Matchups

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dermata Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dermata Therapeutics' short interest history, or implied volatility extrapolated from Dermata Therapeutics options trading.

Pair Trading with Dermata Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dermata Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Dermata Stock

  0.73MBRX Moleculin Biotech Upward RallyPairCorr
  0.75MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Dermata Stock

  0.77DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.73MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.72MDWD Mediwound Financial Report 4th of June 2024 PairCorr
  0.68MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.63EQ Equillium Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to Dermata Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dermata Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dermata Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dermata Therapeutics to buy it.
The correlation of Dermata Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dermata Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dermata Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dermata Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Dermata Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dermata Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dermata Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dermata Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dermata Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
For information on how to trade Dermata Stock refer to our How to Trade Dermata Stock guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Dermata Stock analysis

When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Dermata Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermata Therapeutics. If investors know Dermata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.67)
Return On Assets
(0.67)
Return On Equity
(1.26)
The market value of Dermata Therapeutics is measured differently than its book value, which is the value of Dermata that is recorded on the company's balance sheet. Investors also form their own opinion of Dermata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dermata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermata Therapeutics' market value can be influenced by many factors that don't directly affect Dermata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dermata Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.